Logo for Catalent Inc

Catalent Investor Relations Material

Latest events

Logo for Catalent Inc

Q1 2024

Catalent
Logo for Catalent

Q3 2024

8 May, 2024
Logo for Catalent

Q2 2024

9 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Catalent Inc

Access all reports
Catalent, Inc. is a global contract development and manufacturing organization and provider of research, analytical and clinical services. Catalent offers integrated discovery, development and manufacturing solutions including late stage clinical, sterile process design, commercial production and development solutions for biologics and over-the-counter health drug products. The company also provides comprehensive pharmaceutical services through established early phase development capabilities in small molecule API drug development and late phase clinical development capabilities in global multi-site clinical trials. In addition to biopharmaceuticals and OTC services, Catalent provides an integrated suite of R&D services, including protein chemistry and analytical testing to support non-biotechnology clients developing diagnostics for use in the clinical laboratory. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.